CANCER NEVER RESTS: GENE IMPLICATED IN DISEASE DISRUPTS CIRCADIAN RHYTHM AND METABOLISM
According to researchers, a cancer causing gene may affect the circadian clock and metabolism by binding to promoter regions in genes responsible for maintaining these biological functions.… READ MORE…
BODY PARTS RESPOND TO DAY AND NIGHT INDEPENDENTLY FROM BRAIN
Skin and liver cells appear to have their own circadian clock. Both the liver and skin respond to changes in light and maintain critical function, independent of the brain’s circadian rhythm.… READ MORE…
OBSTRUCTIVE SLEEP APNEA LINKED TO INFLAMMATION AND ORGAN DYSFUNCTION
A new study makes the case that obstructive sleep apnea should be viewed as a low grade chronic inflammatory disease.… READ MORE…
A PATIENT’S SEX MATTERS WHEN IT COMES TO BRAIN CANCER
Researchers report our gender can determine longevity and response to treatment for glioblastoma brain cancer. The study reports male survival is determined by genes that control cell division, where as female survival is often determine by genes that regulate the ability of cancer cells to migrate to different brain areas.… READ MORE…
CANCER HIJACKS THE MICROBIOME TO GLUT ITSELF ON GLUCOSE
Researchers report leukemia undercuts the normal ability of cells to consume glucose, leaving more glucose available to help feed the growth of cancer cells.… READ MORE…
HOW SHIFT WORK DISRUPTS METABOLISM
Researchers report metabolic disruptions often seen in shift workers are not influenced by the brain’s circadian rhythm, but by peripheral oscillators in the liver, gut and pancreas.… READ MORE…
TAU MUTATIONS MAY INCREASE CANCER RISK
A new study reports tau mutations, commonly associated with neurodegenerative diseases like dementia, may also increase the risk of developing cancers. … READ MORE…
EATING AT NIGHT AND SLEEPING BY DAY SWIFTLY ALTERS KEY BLOOD PROTEINS
Researchers report proteins associated with immunity and metabolism can become disrupted following just one simulated night shift.… READ MORE…
MULTIPLE SCLEROSIS DRUG COULD REDUCE PAINFUL SIDE EFFECTS OF COMMON CANCER TREATMENT
According to a new study, a drug used to treat multiple sclerosis could help to treat pain caused by cancer treatments in myeloma patients.… READ MORE…
CANCER OVERRIDES THE CIRCADIAN CLOCK TO SURVIVE
A new study reports misfolded proteins can cause circadian rhythm disruptions which contribute to cancerous tumor growth.… READ MORE…
COMBINATION TREATMENT TARGETING GLUCOSE IN ADVANCED BRAIN CANCER SHOWS PROMISING RESULTS IN PRECLINICAL STUDY
UCLA researchers report erlotinib, an FDA approved drug, reduces glucose uptake in glioblastoma, effectively cutting off nutrients and energy supply to the tumor.… READ MORE…
LINK BETWEEN TOXOPLASMA INFECTION AND COMMON BRAIN DISEASE
A new study in Scientific Reports reports T.gonfii infection may alter, or even amplify some neurological disorders including Alzheimer’s and Parkinson’s disease.… READ MORE…
